Perioral dermatitis: Modern methods of therapy
https://doi.org/10.33667/2078-5631-2022-27-41-44
Abstract
One of the most common causes of perioral dermatitis (PD) is the use of glucocorticosteroids (topically, intranasally, inhaled, systemically). If PD is caused by topical corticosteroids, they must be canceled (according to the authors, without using a sparing reduction technique: a decrease in the frequency of application of corticosteroids and the strength of corticosteroid activity). With a pronounced withdrawal syndrome, it is advisable to start treatment with ‘zero’ therapy: either a complete rejection of the use of external agents, or a lotion with chamomile (5–10 minutes 2 times a day) followed by the use of dermatolichthyol paste (exposure in increasing from 10 minutes to 40 minutes) for 7–10 days, as well as irrigation with hypochlorite thermal water (5–6 times a day). With mild severity of oral dermatitis, monotopic therapy may be prescribed, including cream with activated zinc pyrithione and calcineurin inhibitors. The duration of therapy is determined individually and averages 1.0–1.5 months. In moderate to severe cases, topical therapy should be supplemented with systemic drugs: tetracycline antibiotics (7–10 days) or low-dose isotretinoin (2–4 months). The duration of therapy is determined individually and averages 2 months.
About the Authors
L. S. KruglovaRussian Federation
Kruglova Larisa S., DM Sci (habil.), professor, head of Dept of Dermatovenereology and Cosmetology
Moscow
L. A. Rubtsova
Russian Federation
Rubtsova L.A., resident at Dept of Dermatovenereology and Cosmetology
Moscow
References
1. Clinical guidelines. Perioral dermatitis. Moscow: RODVK. 2020. In Russian.
2. Hoepfner A. et al. Rosacea and perioral dermatitis: A single-center retrospective analysis of the clinical presentation of 1032 patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2020. V. 18. No. 6. P. 561–570. https://doi.org/10.1111/ddg.14120
3. Tolaymat L., Hall M.R. Perioral Dermatitis. 2022 May 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 30247843.
4. Searle T., Ali F.R., Al-Niaimi F. Perioral dermatitis: Diagnosis, proposed etiologies, and management. Journal of Cosmetic Dermatology. 2021. V. 20. No. 12. P. 3839–3848. https://doi.org/10.1111/jocd.14060
5. Kang S. et al. Fitzpatrick’s Dermatology 9th Edition. Vol. 2. 2 vols. 2019.
6. Gray N.A. et al. Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: A systematic review. Journal of the European Academy of Dermatology and Venereology. 2022. V. 36. No. 3. P. 380–390. https://doi.org/10.1111/jdv.17817
7. Charnowski S., Wollenberg A., Reinholz M. Perioral dermatitis successfully treated with topical ivermectin. Annals of Dermatology. 2019. V. 31. No. Suppl. P. S27–S28. https://doi.org/10.5021/ad.2019.31.S.S27
8. Acne and rosacea. Edited by Kruglova L.S. GEOTAR-Media. 2021. 207 p. In Russian.
9. Kruglova L.S., Kotenko K.V., Korchazhkina N.B., Turbovskaya S.N. Physiotherapy in dermatology. Moscow. GEOTAR. 2016. 304 p. In Russian.
Review
For citations:
Kruglova L.S., Rubtsova L.A. Perioral dermatitis: Modern methods of therapy. Medical alphabet. 2022;1(27):41-44. (In Russ.) https://doi.org/10.33667/2078-5631-2022-27-41-44